IndiaSulfonesPurinesHealth Care CostsPiperazinesCosts and Cost AnalysisPhosphodiesterase InhibitorsPhosphodiesterase 5 Inhibitors3',5'-Cyclic-GMP PhosphodiesterasesErectile DysfunctionDrug CostsCost of IllnessCyclic Nucleotide Phosphodiesterases, Type 5Cost ControlDirect Service CostsCost-Benefit AnalysisCost SharingHomosexuality, MalePenile ErectionCost AllocationMethamphetamineVasodilator AgentsCyclic GMPGeorgiaUnsafe SexModels, EconomicRisk-TakingEmployer Health CostsSexual BehaviorQuality-Adjusted Life YearsUnited StatesHealth ResourcesHospitalizationRetrospective StudiesEfficiencyManaged Care ProgramsLength of StayPrevalenceInsurance Claim ReviewRural PopulationDeveloping CountriesTreatment OutcomeFinancing, PersonalAmbulatory CareMarkov ChainsBudgetsDecision TreesTime FactorsInfant, NewbornHealth ServicesCapital ExpendituresDecision Support TechniquesMass ScreeningFees, PharmaceuticalSensitivity and SpecificityFees and ChargesProspective StudiesGreat BritainCross-Sectional StudiesInsurance, Pharmaceutical ServicesDelivery of Health CareEconomics, HospitalAccountingInsurance, HealthEconomics, PharmaceuticalEconomics, MedicalRural HealthDrugs, GenericHIV InfectionsState MedicineHealth PolicyQuestionnairesMedicine, AyurvedicMedicaidRisk FactorsHealth Services AccessibilityPublic SectorProgram EvaluationSocioeconomic FactorsIncidencePrivate SectorOutcome Assessment (Health Care)Data CollectionCohort StudiesFinancing, GovernmentEnergy MetabolismPregnancyUrban PopulationFees, MedicalQuality of LifeFollow-Up StudiesEfficiency, OrganizationalSalaries and Fringe Benefits